Dr. Nadine Jackson McCleary earned a Bachelor of Science in Nursing from the University of Pennsylvania in 1998. She went on to earn both a Masters in Public Health (2002) and medical degree (2003) from Johns Hopkins University Bloomberg School of Public Health and School of Medicine, respectively. She completed residency in internal medicine at Johns Hopkins Hospital in 2006 and fellowship in clinical hematology and oncology at Dana-Farber/Partners CancerCare in 2009. Dr. McCleary joined the staff of Dana-Farber Cancer Institute and Brigham and Women’s Hospital in 2009 where she is a medical oncologist and clinical investigator. Her research is focused on improving health and treatment outcomes for older patients with cancer.
Dana-Farber Cancer Institute450 Brookline AvenueBoston MA, 02215Get Directions
Health and treatment outcomes of older patients with gastrointestinal cancerPrognostic/Predictive factors of survival for older patients with gastrointestinal cancer
Dr. McCleary’s overall career objective is to apply emerging scientific knowledge about cancer biology, epidemiology, geriatrics and pharmacology to treatment decisions that clinicians face every day. Her focus is on treatment decision making in the geriatric population where knowledge of tumor biology, drug efficacy, and host specific factors such as comorbidity, must be synthesized to facilitate informed choices. Her research objective is to develop an age-specific prognostic model for older adults with colorectal cancer. As a faculty member of Gastrointestinal Cancer Center at the Dana-Farber Cancer Institute, she divides her time between patient care and clinical investigation in geriatric oncology.